1. Home
  2. EFC vs IMTX Comparison

EFC vs IMTX Comparison

Compare EFC & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EFC

Ellington Financial Inc.

HOLD

Current Price

$13.45

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Immatics N.V.

IMTX

Immatics N.V.

HOLD

Current Price

$9.88

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFC
IMTX
Founded
2007
N/A
Country
United States
Germany
Employees
500
407
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EFC
IMTX
Price
$13.45
$9.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$14.55
$19.00
AVG Volume (30 Days)
1.5M
337.0K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
11.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$43.05
$25.91
P/E Ratio
$9.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.28
$5.05
52 Week High
$14.12
$12.41

Technical Indicators

Market Signals
Indicator
EFC
IMTX
Relative Strength Index (RSI) 48.81 49.91
Support Level $13.23 $9.61
Resistance Level $13.80 $10.64
Average True Range (ATR) 0.21 0.50
MACD -0.02 0.09
Stochastic Oscillator 40.68 70.90

Price Performance

Historical Comparison
EFC
IMTX

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. It acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

About IMTX Immatics N.V.

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: